Podcast Episodes

Back to Search
Pharmaceutical Executive Daily: Nine European Drugmakers Note Concern Over Region's Pharma Investments
Pharmaceutical Executive Daily: Nine European Drugmakers Note Concern Over Region's Pharma Investments

Nine major European drugmakers warn the region risks losing pharma investment, Novartis licenses a preclinical radioligand therapy asset from BoomRay…

1 month, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: AbbVie Forms Ai-Powered Drug Discovery Partnership with Iambic
Pharmaceutical Executive Daily: AbbVie Forms Ai-Powered Drug Discovery Partnership with Iambic

1 month, 4 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Fayuvi
Pharmaceutical Executive Daily: FDA Approves Fayuvi

FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience …

2 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves New Indication for Kerendia
Pharmaceutical Executive Daily: FDA Approves New Indication for Kerendia

FDA approves Kerendia as the first new treatment for kidney disease in type 1 diabetes in decades, Novo, Roche, and Aethlon Medical strike major deal…

2 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: Novo Partners with Anthropic
Pharmaceutical Executive Daily: Novo Partners with Anthropic

Novo teams up with Anthropic on AI-driven drug discovery, Sling Therapeutics and Circle Pharma close major financing rounds, and IQVIA's Phil Ford ma…

2 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: Sanofi & Cheplapharm Form Strategic Partnership
Pharmaceutical Executive Daily: Sanofi & Cheplapharm Form Strategic Partnership

GSK is acquiring a trispecific T-cell engager from Chimagen Biosciences and Sanofi expanding its manufacturing partnership with Cheplapharm, Stewart …

2 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: Novo Nordisk Enters Rebrand
Pharmaceutical Executive Daily: Novo Nordisk Enters Rebrand

Cellectis pivots from CAR-T to in vivo gene editing, Novo Nordisk rebrands as "Novo" to sharpen its competitive edge in obesity and diabetes care, an…

2 months ago

Short Long
View Episode
Pharmaceutical Executive Daily: Novartis Shareholders Raise Concerns over M&A Strategy
Pharmaceutical Executive Daily: Novartis Shareholders Raise Concerns over M&A Strategy

Novartis investors intensify pressure on the company's M&A strategy after a string of trial failures, Michelle Carnahan argues health care needs an o…

2 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: David Samra Calls For Novartis Board Shake-Up
Pharmaceutical Executive Daily: David Samra Calls For Novartis Board Shake-Up

2 months, 1 week ago

Short Long
View Episode
340B Under Pressure: Inside Pharma's Push for Greater Clarity
340B Under Pressure: Inside Pharma's Push for Greater Clarity

In this episode of Pricing & Policy with Model N, Jesse Mendelsohn, senior vice president at Model N, joins host Mike Christel to examine the growin…

2 months, 1 week ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us